Device
Multimodal Thermal Therapy
Multimodal Thermal Therapy is a medical device with 2 clinical trials. Currently 1 active trials ongoing.
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
1(50%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
2
all time
Status Distribution
Active(2)
Detailed Status
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
1
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
not_yet_recruiting150%
recruiting150%
Recent Activity
1 active trials
Showing 2 of 2
not_yet_recruitingnot_applicable
Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC
NCT07596134
recruitingnot_applicable
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
NCT06794073
Clinical Trials (2)
Showing 2 of 2 trials
NCT07596134Not Applicable
Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC
NCT06794073Not Applicable
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2